Literature DB >> 30862413

Relapsing encephalopathy with cerebellar ataxia are caused by variants involving p.Arg756 in ATP1A3.

Pascal Sabouraud1, Audrey Riquet2, Marie-Aude Spitz3, Kumaran Deiva4, Sona Nevsimalova5, Cyril Mignot6, Gaëtan Lesca7, Nathalie Bednarek8, Diane Doummar9, Christine Pietrement10, Vincent Laugel11.   

Abstract

Mutations in ATP1A3 lead to different phenotypes having in common acute neurological decompensation episodes triggered by a specific circumstance and followed by sequelae. Alongside Alternating Hemiplegia of Childhood (AHC), Rapid-onset Dystonia Parkinsonism (RDP) and Cerebellar ataxia, Areflexia, Pes cavus, Optic atrophy, Sensorineural hearing loss syndrome (CAPOS), a new Relapsing Encephalopathy with Cerebellar Ataxia (RECA) phenotype was published in 2015. We describe herein eight new pediatric cases. Most of them had no specific history when the first neurological decompensation episode occurred, before the age of 5 years, triggered by fever with severe paralytic hypotonia followed by ataxia with or without abnormal movements. Neurological sequelae with ataxia as the predominant symptom were present after the first episode in three cases and after at least one subsequent relapse in five cases. Five of the eight cases had a familial involvement with one of the two parents affected. The phenotype-genotype correlation is unequivocal with the causal substitution always located at position 756. The pathophysiology of the dysfunctions of the mutated ATPase pump, triggered by fever is unknown. Severe recurrent neurological decompensation episodes triggered by fever, without any metabolic cause, should lead to the sequencing of ATP1A3.
Copyright © 2019 European Paediatric Neurology Society. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  ATP1A3; Ataxia; Child; Movement disorder

Mesh:

Substances:

Year:  2019        PMID: 30862413     DOI: 10.1016/j.ejpn.2019.02.004

Source DB:  PubMed          Journal:  Eur J Paediatr Neurol        ISSN: 1090-3798            Impact factor:   3.140


  12 in total

1.  Long-Term Follow-Up of a Patient with a De Novo p.Arg769Cys Mutation in the ATP1A3 Gene.

Authors:  Anjali Chouksey; Asish Vijayaraghavan; Sony Mohan; Srija Inturi; A T Prabhakar; Vivek Mathew
Journal:  Mov Disord Clin Pract       Date:  2021-09-10

Review 2.  Clinical and Genetic Overview of Paroxysmal Movement Disorders and Episodic Ataxias.

Authors:  Giacomo Garone; Alessandro Capuano; Lorena Travaglini; Federica Graziola; Fabrizia Stregapede; Ginevra Zanni; Federico Vigevano; Enrico Bertini; Francesco Nicita
Journal:  Int J Mol Sci       Date:  2020-05-20       Impact factor: 5.923

3.  Recessive Inheritance of Congenital Hydrocephalus With Other Structural Brain Abnormalities Caused by Compound Heterozygous Mutations in ATP1A3.

Authors:  August A Allocco; Sheng Chih Jin; Phan Q Duy; Charuta G Furey; Xue Zeng; Weilai Dong; Carol Nelson-Williams; Jason K Karimy; Tyrone DeSpenza; Le T Hao; Benjamin Reeves; Shozeb Haider; Murat Gunel; Richard P Lifton; Kristopher T Kahle
Journal:  Front Cell Neurosci       Date:  2019-09-26       Impact factor: 5.505

Review 4.  ATP1A3-Related Disorders: An Ever-Expanding Clinical Spectrum.

Authors:  Philippe A Salles; Ignacio F Mata; Tobias Brünger; Dennis Lal; Hubert H Fernandez
Journal:  Front Neurol       Date:  2021-04-01       Impact factor: 4.003

5.  De novo ATP1A3 variants cause polymicrogyria.

Authors:  Satoko Miyatake; Mitsuhiro Kato; Takuma Kumamoto; Tomonori Hirose; Eriko Koshimizu; Takaaki Matsui; Hideyuki Takeuchi; Hiroshi Doi; Keisuke Hamada; Mitsuko Nakashima; Kazunori Sasaki; Akio Yamashita; Atsushi Takata; Kohei Hamanaka; Mai Satoh; Takabumi Miyama; Yuri Sonoda; Momoko Sasazuki; Hiroyuki Torisu; Toshiro Hara; Yasunari Sakai; Yushi Noguchi; Mazumi Miura; Yoko Nishimura; Kazuyuki Nakamura; Hideyuki Asai; Nodoka Hinokuma; Fuyuki Miya; Tatsuhiko Tsunoda; Masami Togawa; Yukihiro Ikeda; Nobusuke Kimura; Kaoru Amemiya; Asako Horino; Masataka Fukuoka; Hiroko Ikeda; Goni Merhav; Nina Ekhilevitch; Masaki Miura; Takeshi Mizuguchi; Noriko Miyake; Atsushi Suzuki; Shouichi Ohga; Hirotomo Saitsu; Hidehisa Takahashi; Fumiaki Tanaka; Kazuhiro Ogata; Chiaki Ohtaka-Maruyama; Naomichi Matsumoto
Journal:  Sci Adv       Date:  2021-03-24       Impact factor: 14.136

6.  Relapsing Neurological Complications in a Child With ATP1A3 Gene Mutation and Influenza Infection: A Case Report.

Authors:  Raffaella Pisapia; Nicolina Capoluongo; Giulia Palmiero; Carlo Tascini; Carolina Rescigno
Journal:  Front Neurol       Date:  2021-12-15       Impact factor: 4.003

7.  Genetically altered animal models for ATP1A3-related disorders.

Authors:  Hannah W Y Ng; Jennifer A Ogbeta; Steven J Clapcote
Journal:  Dis Model Mech       Date:  2021-10-06       Impact factor: 5.732

8.  Chinese patients with p.Arg756 mutations of ATP1A3: Clinical manifestations, treatment, and follow-up.

Authors:  Weihua Zhang; Jiuwei Li; Xiuwei Zhuo; Ji Zhou; Weixing Feng; Shuai Gong; Xiaotun Ren; Changhong Ding; Tongli Han; Fang Fang
Journal:  Pediatr Investig       Date:  2022-02-25

Review 9.  Combined dystonias: clinical and genetic updates.

Authors:  Anne Weissbach; Gerard Saranza; Aloysius Domingo
Journal:  J Neural Transm (Vienna)       Date:  2020-10-24       Impact factor: 3.575

Review 10.  Variants of ATP1A3 in residue 756 cause a separate phenotype of relapsing encephalopathy with cerebellar ataxia (RECA)-Report of two cases and literature review.

Authors:  Mateusz Biela; Malgorzata Rydzanicz; Krystyna Szymanska; Karolina Pieniawska-Smiech; Aleksandra Lewandowicz-Uszynska; Joanna Chruszcz; Lucyna Benben; Malgorzata Kuzior-Plawiak; Pawel Szyld; Aleksandra Jakubiak; Leszek Szenborn; Rafal Ploski; Robert Smigiel
Journal:  Mol Genet Genomic Med       Date:  2021-08-02       Impact factor: 2.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.